Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
03/16/2005 | CN1596269A A novel G protein-coupled receptor, gave 10 |
03/16/2005 | CN1596257A Novel crystalline compound |
03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
03/16/2005 | CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
03/16/2005 | CN1596112A Benzothiazole derivatives |
03/16/2005 | CN1596104A Modified release dosage forms |
03/16/2005 | CN1596102A Regulation dosage forms |
03/16/2005 | CN1596101A Fondant composition contained dosage forms |
03/16/2005 | CN1596100A Edible composition and dosage form comprising an edible shell |
03/16/2005 | CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants) |
03/16/2005 | CN1594308A Tectoridin isoflavone derivatives, their preparation process, and anti-virus medicines with tectoridin isoflavone derivatives as active components |
03/16/2005 | CN1593625A Orally disintegrating tablet of throat clearing medicine and its preparation process |
03/16/2005 | CN1593622A Orally disintegrating tablet of 'Shuanghuanglian' and its preparation |
03/16/2005 | CN1593619A Detoxification Chinese medicine |
03/16/2005 | CN1593595A Lung clearing preparation for treating respiratory virus infection diseases |
03/16/2005 | CN1593594A Chinese traditional medicinal composition and its preparation process and usage |
03/16/2005 | CN1593587A Lung nourishing and regulating pills for the lung pattern disease and its preparation method |
03/16/2005 | CN1593560A Chinese medicinal prescription for treating chronic bronchitis |
03/16/2005 | CN1593558A Sarcandra extract and its application |
03/16/2005 | CN1593554A Medicine for treating diseases of respiratory system |
03/16/2005 | CN1593525A Throat ache relieving medicine |
03/16/2005 | CN1593513A Dripping pills of 'Zhenkening' for stopping cough and its preparing process |
03/16/2005 | CN1593487A Compound buccal lozenge of licorice and its preparing process |
03/16/2005 | CN1593449A self emulsifying soft capsule of breviscapine and its preparation |
03/16/2005 | CN1593429A Novel oral guacetisal solid preparation and its preparing method |
03/16/2005 | CN1593414A Powder inhalation of tiotropium bromide capsule type and its preparation method |
03/16/2005 | CN1593413A Sustained release compound capsules and its preparation method |
03/16/2005 | CN1193029C New 7-amino pyrido[2, 3-d] pyrimidine derivative, its composition and use |
03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
03/16/2005 | CN1193003C Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha |
03/16/2005 | CN1192798C Vaccine |
03/16/2005 | CN1192797C Combination vaccine against streptocouus pneumoniae and respiratory syncytial virus (RSV) |
03/16/2005 | CN1192792C Chinese medicine for treating chronic obstructive lung disease |
03/16/2005 | CN1192791C Cold preventing Chinese medicine powder and its preparation method |
03/16/2005 | CN1192773C Cyclic amine CCR3 antagonisis |
03/15/2005 | US6867313 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
03/15/2005 | US6867300 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
03/15/2005 | US6867299 Inosine monophosphate dehydrogenase (IMPDH); use as immunosuppressants, anticancer agents and antiviral agents |
03/15/2005 | US6867222 Nociceptin analogs |
03/15/2005 | US6867221 Cyclic amine compounds and pharmaceutical composition containing the same |
03/15/2005 | US6867214 Quinazoline derivatives and pharmaceutical applications thereof |
03/15/2005 | US6867211 Fused nitrogen biheterocyclic derivatives; immunomodulaters; inhibiting cytokine release |
03/15/2005 | US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid |
03/15/2005 | US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
03/15/2005 | CA2323047C Prodrugs of benzofuranylmethyl carbamate nk, antagonists |
03/10/2005 | WO2005021548A2 Substituted 8-heteroaryl xanthines |
03/10/2005 | WO2005021518A1 Condensed ring compound and use thereof |
03/10/2005 | WO2005021513A1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases |
03/10/2005 | WO2005021037A1 Composition comprising a pulmonary surfactant and a pde2 inhibitor |
03/10/2005 | WO2004105731A8 Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea |
03/10/2005 | WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
03/10/2005 | WO2003073990A3 Treatment for asthma or allergies |
03/10/2005 | WO2003010290A3 Novel class ii cytokine receptors and uses thereof |
03/10/2005 | US20050054851 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
03/10/2005 | US20050054719 Dimeric compounds and their use as anti-viral agents |
03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
03/10/2005 | US20050054664 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
03/10/2005 | US20050054653 Pteridine derivatives, method of producing them and their application |
03/10/2005 | US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
03/10/2005 | US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders |
03/10/2005 | US20050054593 New drug |
03/10/2005 | US20050054588 Methods and compositions for the treatment of asthma and related disorders |
03/10/2005 | US20050054587 Novel therapeutic indication of azithromycin for treatment of non-infective inflamatory diseases |
03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
03/10/2005 | US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection |
03/10/2005 | US20050053659 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness |
03/10/2005 | US20050053654 able to disintegrate in buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60 seconds, containing fexofenadine or its salt and a binder, in the form of a coated granule, and excipients such as disintegrating agent, a soluble diluent, and a lubricant |
03/10/2005 | US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis |
03/10/2005 | US20050053553 Combined doses of formoterol and fluticasone |
03/10/2005 | CA2536553A1 Substituted 8-heteroaryl xanthines |
03/10/2005 | CA2536458A1 Composition comprising a pulmonary surfactant and a pde2 inhibitor |
03/10/2005 | CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
03/09/2005 | EP1511845A2 Immunostimulatory oligonucleotides and uses thereof |
03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
03/09/2005 | EP1511743A1 Pyrazole-derivatives as p38 kinase inhibitors |
03/09/2005 | EP1511742A1 Kinase inhibitors |
03/09/2005 | EP1511737A1 Aryloximes |
03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
03/09/2005 | EP1511516A1 Topically applicable pharmaceutical preparation |
03/09/2005 | EP1511512A1 Novel uses of parapoxvirus preparations |
03/09/2005 | EP1511502A2 Probiotic therapies using lactobacillus reuteri |
03/09/2005 | EP1511500A2 Combination of anti-muscarinic agents and non-glucocorticoid steroids |
03/09/2005 | EP1511499A2 Immunomodulatory compounds and methods of use thereof |
03/09/2005 | EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
03/09/2005 | EP1511481A1 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
03/09/2005 | EP1511466A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd |
03/09/2005 | EP1307440B1 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
03/09/2005 | EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases |
03/09/2005 | EP1126849B1 Heterocyclic potassium channel inhibitors |